Element Biosciences launched Vitari, its first high‑throughput sequencing platform, promising up to 3 terabytes per paired‑end 150 bp run in 36 hours and the ability to sequence a 30X human genome for an estimated $100. Element positions Vitari as a cost‑and‑throughput challenger in the sequencing market. The platform’s economics and run metrics, if realized at scale, could reshape sequencing access for large‑scale genomics projects and clinical sequencing workflows. Competitors and service providers will watch adoption, reagent costs, and real‑world performance metrics closely as customers validate throughput and quality claims.